Atara Biotherapeutics Inc. (NASDAQ: ATRA)
$10.8800
+0.9500 ( +4.31% ) 63.7K
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).
Market Data
Open
$10.8800
Previous close
$9.9300
Volume
63.7K
Market cap
$60.07M
Day range
$9.9250 - $11.2050
52 week range
$6.5000 - $39.5000
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | Apr 02, 2024 |
4 | Insider transactions | 1 | Apr 02, 2024 |
4 | Insider transactions | 1 | Apr 02, 2024 |
4 | Insider transactions | 1 | Apr 02, 2024 |
4 | Insider transactions | 1 | Apr 02, 2024 |
8-k | 8K-related | 11 | Mar 29, 2024 |
10-k | Annual reports | 96 | Mar 28, 2024 |
8-k | 8K-related | 12 | Mar 28, 2024 |
4 | Insider transactions | 1 | Mar 06, 2024 |
4 | Insider transactions | 1 | Mar 06, 2024 |